Forget injections. A new drug promises to be just as effective as Ozempic  — but is taken as a daily pill. Called orforglipron, the results of a new clinical trial announced Thursday by manufacturer Eli Lilly suggest that the pill could be a breakthrough in a class of drugs called GLP-1 agonists, which have become popular for their dual potential in helping with weight loss and treating diabetes.  Though they have taken the world by storm, GLP-1 drugs like semaglutide — sold as Ozempic and Wegovy — remain costly, require refrigeration, and need to be injected, imposing significant hurdles on […]